Search results for “Integrin antagonist” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,052 patents, we discovered top 81 key players by total patent application. Merck Patent GmbH, Genentech, Inc., G.D. Searle LLC are dominant in this area. They take 28.04% of the total patent filing.
Merck Patent GmbH
Hessen, Germany
Patent: 120
Genentech, Inc.
California, United States
Patent: 88
G.D. Searle LLC
Illinois, United States
Patent: 87
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 76
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 72
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 68
Merck & Co., Inc.
New Jersey, United States
Patent: 52
Pharmacia Corp.
New Jersey, United States
Patent: 30
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 27
Novartis AG
Basel-Stadt, Switzerland
Patent: 25
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 120 patents applied in the last 5 years. We discover 27 most active companies in this area. The fast-growing Genentech, Inc., Oxurion NV, Protagonist Therapeutics, Inc. take 41.67% of patent filing during this period.
Genentech, Inc.
California, United States
Patent: 21
Oxurion NV
Vlaams-Brabant, Belgium
Patent: 18
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 11
The General Hospital Corp.
Massachusetts, United States
Patent: 10
St. Louis University
Missouri, United States
Patent: 8
Bayer Pharma AG
Berlin, Germany
Patent: 8
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 4
Indalo Therapeutics, Inc.
Missouri, United States
Patent: 4
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 3
Ocuterra Therapeutics, Inc.
Massachusetts, United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 120 patents in last 5 years, we discover 12 new entrants. Oxurion NV, Bayer Pharma AG, Morphic Therapeutic, Inc. are the most active new entrants in this area.
Oxurion NV
Vlaams-Brabant, Belgium
Patent: 18
Bayer Pharma AG
Berlin, Germany
Patent: 8
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 3
Advanced Accelerator Applications International SA
Switzerland
Patent: 2
Gilead Sciences, Inc.
California, United States
Patent: 2
Advanced Accelerator Applications (Italy) SRL
Isernia, Italy
Patent: 2
Apeloa Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Hangzhou Puluo Pharmaceutical Research Institute Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Zealand Pharma A/S
Hovedstaden, Denmark
Patent: 2
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 150 patents, we discovered top 12 universities and scientific research institutions by total patent application. St. Louis University, The Scripps Research Institute, Imperial College London are dominant in this area. They take 56.00% of the total patent filing.
St. Louis University
Missouri, United States
Patent: 44
The Scripps Research Institute
California, United States
Patent: 19
Imperial College London
United Kingdom
Patent: 14
The Rockefeller University
New York, United States
Patent: 8
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 8
Hiroshima University
Hiroshima-ken, Japan
Patent: 3
University of Southern California
California, United States
Patent: 2
Rutgers State University of New Jersey
New Mexico, United States
Patent: 2
The University of Nottingham
NOTTINGHAM, United Kingdom
Patent: 2
Washington University in St. Louis
Missouri, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: